#ArtificialIntelligence

Digital

BIO-Europe Spring interview with Dr Olga Nissan

On collaboration, computational chemistry, and cutting-edge ...

Dr Olga Nissan, vice president of business development at Evogene discusses collaboration with Google Cloud & generative design of small molecules.

Market Access

Is AI the missing link in fixing MLR – or the reason it brea...

Somewhere in a shared drive at a mid-size pharma company, there is a folder labelled “Q3 Messaging FINAL v3 (2).” Inside it are three Word documents with tracked changes from four people, n

Digital

We can’t fix modern healthcare with 1950s solutions. AI is t...

In today’s NHS, the urgency of embracing artificial intelligence (AI) is no longer a matter of innovation - it’s a matter of survival.

Patients

Responding to global greying: Does Nordic AgeTech hold the b...

It’s a fact of life that we’re all living longer, which is reshaping the way healthcare is delivered.

Digital

What is the future of technology in health data?

From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things.

Digital

From pilots to impact: What it really takes to scale GenAI i...

Just a year ago, the GenAI buzz in pharma felt like the start of a gold rush. Leaders greenlit pilots. Teams spun up proof-of-concepts.

On collaboration, computational chemistry, and cutting-edge ...

Is AI the missing link in fixing MLR – or the reason it brea...

We can’t fix modern healthcare with 1950s solutions. AI is t...

Responding to global greying: Does Nordic AgeTech hold the b...

What is the future of technology in health data?

From pilots to impact: What it really takes to scale GenAI i...

Chiesi signs $1.9bn deal to buy KalVista and its HAE drug

Using AI-driven synthetic personas to take your insights fur...

#ArtificialIntelligence

Editor's Picks